Завершено
Фаза III
Россия
arbaclofen · RVL Pharmaceuticals, Inc.
A One Year, Open Label, Dose Escalation Study To Evaluate the Long-Term Safety of Arbaclofen Extended Release Tablets (AERT) in Multiple Sclerosis Subjects With Spasticity